ICD-10-CM Code Z79: Long term (current) drug therapy and Related Diagnosis Codes.


The ICD-10-CM (the International Classification of Diseases, Tenth Revision, Clinical Modification) is a standardized coding system used when classifying diseases and medical conditions. Healthcare providers report these codes on Medical claims when diagnosing patient care.

Explore ICD-10-CM codes, organized by chapters based on body systems and medical conditions, as outlined in the International Classification of Diseases, Tenth Revision, Clinical Modification.

Tip: Have a specific ICD-10-CM code? Use our simple to use ICD-10-CM Code Lookup tool.

Eclaims - ICD-10-CM Tabular Code List v1.0.0

A categorized list of ICD-10-CM codes organized by chapters based on body systems or medical conditions, according to the International Classification of Diseases, Tenth Revision, Clinical Modification.

Questions
Results
  • Z79 - Long term (current) drug therapy
    • Z79.0 - Long term (current) use of anticoagulants and antithrombotics/antiplatelets
      • Z79.01 - Long term (current) use of anticoagulants
      • Z79.02 - Long term (current) use of antithrombotics/antiplatelets
    • Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)
    • Z79.2 - Long term (current) use of antibiotics
    • Z79.3 - Long term (current) use of hormonal contraceptives
    • Z79.4 - Long term (current) use of insulin
    • Z79.5 - Long term (current) use of steroids
      • Z79.51 - Long term (current) use of inhaled steroids
      • Z79.52 - Long term (current) use of systemic steroids
    • Z79.6 - Long term (current) use of immunomodulators and immunosuppressants
      • Z79.60 - Long term (current) use of unspecified immunomodulators and immunosuppressants
      • Z79.61 - Long term (current) use of immunomodulator
      • Z79.62 - Long term (current) use of immunosuppressant
        • Z79.620 - Long term (current) use of immunosuppressive biologic
        • Z79.621 - Long term (current) use of calcineurin inhibitor
        • Z79.622 - Long term (current) use of Janus kinase inhibitor
        • Z79.623 - Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
        • Z79.624 - Long term (current) use of inhibitors of nucleotide synthesis
      • Z79.63 - Long term (current) use of chemotherapeutic agent
        • Z79.630 - Long term (current) use of alkylating agent
        • Z79.631 - Long term (current) use of antimetabolite agent
        • Z79.632 - Long term (current) use of antitumor antibiotic
        • Z79.633 - Long term (current) use of mitotic inhibitor
        • Z79.634 - Long term (current) use of topoisomerase inhibitor
      • Z79.64 - Long term (current) use of myelosuppressive agent
      • Z79.69 - Long term (current) use of other immunomodulators and immunosuppressants
    • Z79.8 - Other long term (current) drug therapy
      • Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
        • Z79.810 - Long term (current) use of selective estrogen receptor modulators (SERMs)
        • Z79.811 - Long term (current) use of aromatase inhibitors
        • Z79.818 - Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • Z79.82 - Long term (current) use of aspirin
      • Z79.83 - Long term (current) use of bisphosphonates
      • Z79.84 - Long term (current) use of oral hypoglycemic drugs
      • Z79.85 - Long-term (current) use of injectable non-insulin antidiabetic drugs
      • Z79.89 - Other long term (current) drug therapy
        • Z79.890 - Hormone replacement therapy
        • Z79.891 - Long term (current) use of opiate analgesic
        • Z79.899 - Other long term (current) drug therapy

Note: The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes are developed and maintained by the Centers for Disease Control and Prevention (CDC). CDC's National Center for Health Statistics (NCHS) is responsible for the clinical modification of ICD-10 for use in the United States. The World Health Organization (WHO), which owns and publishes ICD-10, authorized NCHS to develop ICD-10-CM. All modifications to ICD-10 must conform to WHO's established ICD structure and conventions. All rights are reserved by the respective entities.